{"id":4090,"date":"2025-02-07T13:05:58","date_gmt":"2025-02-07T13:05:58","guid":{"rendered":"https:\/\/www.almacgroup.com\/clinical-technologies\/?p=4090"},"modified":"2025-03-04T11:13:44","modified_gmt":"2025-03-04T11:13:44","slug":"innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese","status":"publish","type":"post","link":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/","title":{"rendered":"Innovative IRT Solutions: Almac\u2019s Commitment to Clinical Trial Quality and Innovation in APAC &#8211; Chinese"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\" id=\"h-\u9769\u65b0\u7684-irt-\u89e3\u51b3\u65b9\u6848-almac-\u5bf9\u5728\u4e9a\u592a\u5730\u533a\u4e34\u5e8a\u5b9e\u9a8c\u8d28\u91cf\u4e0e\u521b\u65b0\u7684\u627f\u8bfa\">\u9769\u65b0\u7684 IRT \u89e3\u51b3\u65b9\u6848\uff1aAlmac \u5bf9\u5728\u4e9a\u592a\u5730\u533a\u4e34\u5e8a\u5b9e\u9a8c\u8d28\u91cf\u4e0e\u521b\u65b0\u7684\u627f\u8bfa<\/h2>\n\n\n\n<p><strong>Joseph Goh &#8211; <\/strong><em>Design Manager &#8211; \u7cfb\u7edf\u8bbe\u8ba1\u7ecf\u7406 <\/em>|<em> Almac Clinical Technologies<\/em><\/p>\n\n\n\n<p><strong>\u7b80\u4ecb<\/strong><\/p>\n\n\n\n<p>\u6211\u662f Joseph\uff0c\u5728 Almac \u62c5\u4efb\u7cfb\u7edf\u8bbe\u8ba1\u7ecf\u7406\u8fd1\u516b\u5e74\u3002\u6211\u6765\u81ea\u65b0\u52a0\u5761\uff0c\u5e76\u5728\u6b64\u5f00\u542f\u4e86\u6211\u7684\u804c\u4e1a\u751f\u6daf\uff0c\u4f46\u6211\u73b0\u5728\u5df2\u5728\u65e5\u672c\u5de5\u4f5c\u8d85\u8fc7\u4e24\u5e74\u3002<\/p>\n\n\n\n<p><strong>\u6a1f\u5b9c\u673a\u573a\u6210\u529f\u80cc\u540e\u7684\u79d8\u5bc6<\/strong><\/p>\n\n\n\n<p>\u4f5c\u4e3a\u4e00\u540d\u65b0\u52a0\u5761\u4eba\uff0c\u6211\u4e3a\u6211\u4eec\u7684\u6a1f\u5b9c\u56fd\u9645\u673a\u573a\u6df1\u611f\u81ea\u8c6a\u3002\u6a1f\u5b9c\u673a\u573a\u4e8e2013 \u81f3 2020 \u5e74\u8fde\u7eed\u516b\u5e74\u8749\u8054\u5168\u7403\u6700\u4f73\u673a\u573a\uff0c\u517112\u6b21\u8363\u81ba\u6842\u51a0\u3002\u8fd9\u4efd\u9a84\u4eba\u6210\u7ee9\u7684\u80cc\u540e\uff0c\u662f\u5bf9\u4ee5\u6d41\u7a0b\u4e3a\u5bfc\u5411\u7684\u9ad8\u54c1\u8d28\u670d\u52a1\u7684\u575a\u6301\u3002\u4f8b\u5982\uff0c\u6a1f\u5b9c\u673a\u573a\u4e0e\u5404\u822a\u7a7a\u516c\u53f8\u5b9a\u5236\u89e3\u51b3\u65b9\u6848\u548c\u5408\u4f5c\u4f19\u4f34\u5173\u7cfb\uff0c\u800c\u975e\u4f7f\u7528\u901a\u7528\u6a21\u5f0f\u3002\u8fd9\u6709\u52a9\u4e8e\u6a1f\u5b9c\u673a\u573a\u63a8\u52a8\u822a\u7a7a\u4ea4\u901a\u548c\u8fde\u901a\u6027\uff0c\u4fdd\u6301\u5176\u4e00\u6d41\u822a\u7a7a\u67a2\u7ebd\u7684\u5730\u4f4d\u3002\u673a\u573a\u7684\u613f\u666f\u5305\u62ec\u63d0\u4f9b\u72ec\u5230\u7684\u6a1f\u5b9c\u4f53\u9a8c\u2014\u2014\u6253\u9020\u4e2a\u6027\u5316\u3001\u8f7b\u677e\u65e0\u5fe7\u3001\u5145\u6ee1\u60ca\u559c\u7684\u65c5\u7a0b\u3002\u8fd9\u610f\u5473\u7740\u9700\u8981\u4e0d\u65ad\u6539\u8fdb\u3001\u66f4\u65b0\u6216\u65b0\u5efa\u673a\u573a\u8bbe\u65bd\uff0c\u4ece\u800c\u8d85\u8d8a\u5ba2\u6237\u548c\u4e58\u5ba2\u7684\u671f\u5f85\u3002\u6a1f\u5b9c\u673a\u573a\u7684\u5353\u8d8a\u6587\u5316\u4f7f\u5176\u591a\u5e74\u6765\u59cb\u7ec8\u4fdd\u6301\u4e00\u6d41\u673a\u573a\u7684\u5730\u4f4d\u3002\u6211\u4e3e\u8fd9\u4e2a\u4f8b\u5b50\u4e5f\u662f\u4e3a\u4e86\u8bf4\u660e\uff0c\u4e3a\u4ec0\u4e48 Almac \u80fd\u59cb\u7ec8\u4fdd\u6301 IRT \u4f18\u8d28\u4f9b\u5e94\u5546\u7684\u5730\u4f4d\u3002<\/p>\n\n\n\n<p><strong>IRT <\/strong><strong>\u7cfb\u7edf\u7684\u771f\u6b63\u4ef7\u503c<\/strong><\/p>\n\n\n\n<p>\u5f53\u524d\uff0cIRT \u7cfb\u7edf\u4e0d\u65ad\u589e\u52a0\u65b0\u7684\u7279\u6027\u548c\u529f\u80fd\uff0c\u5e76\u62e5\u6709\u7f8e\u8f6e\u7f8e\u5942\u7684\u7528\u6237\u754c\u9762\u3002\u8fd9\u4e9b\u56fa\u7136\u91cd\u8981\uff0c\u7136\u800c\uff0c\u6211\u4eec\u9700\u8981\u601d\u8003\u7684\u662f\uff1a\u7cfb\u7edf\u529f\u80fd\u7a76\u7adf\u53ef\u4ee5\u6269\u5c55\u5230\u4f55\u79cd\u7a0b\u5ea6\uff1fIRT \u4f9b\u5e94\u5546\u63d0\u4f9b\u7684\u6838\u5fc3\u529f\u80fd\u5927\u540c\u5c0f\u5f02\uff0c \u771f\u6b63\u8ba9 Almac \u8131\u9896\u800c\u51fa\uff0c\u533a\u522b\u4e8e\u7ade\u4e89\u5bf9\u624b\u7684\u4e00\u4e2a\u5173\u952e\u56e0\u7d20\u662f\u6211\u4eec\u80fd\u591f\u63d0\u4f9b\u7684\u6d41\u7a0b\u3001\u670d\u52a1\u548c\u6280\u672f\u652f\u6301\u3002<\/p>\n\n\n\n<p><strong>\u8d28\u91cf\u59cb\u4e8e\u8bbe\u8ba1<\/strong><\/p>\n\n\n\n<p>\u521d\u4efb\u7cfb\u7edf\u8bbe\u8ba1\u7ecf\u7406 (DM) \u65f6\uff0c\u6211\u88ab\u544a\u77e5\u8fd9\u4e2a\u5c97\u4f4d\u9700\u8981\u5b66\u4e60\u76f8\u5f53\u957f\u4e00\u6bb5\u65f6\u95f4\u624d\u80fd\u5b8c\u5168\u80dc\u4efb\uff0c\u56e0\u4e3a\u5b83\u6d89\u53ca\u5468\u5bc6\u7684\u89c4\u5212\u3001\u4e25\u683c\u7684\u8bbe\u8ba1\u6807\u51c6\u4ee5\u53ca\u5168\u65b9\u4f4d\u7684\u8d28\u91cf\u7ba1\u63a7\u3002\u4f5c\u4e3a DM\uff0c\u6211\u4eec\u4e0d\u4ec5\u9700\u8981\u901a\u8fc7\u7cfb\u7edf\u5316\u57f9\u8bad\uff0c\u66f4\u8981\u5177\u5907\u6df1\u5165\u7406\u89e3\u7814\u7a76\u65b9\u6848\u7684\u80fd\u529b\uff0c\u624d\u80fd\u8bbe\u8ba1\u51fa\u6700\u4f18\u7684 IRT \u89e3\u51b3\u65b9\u6848\u3002\u5728\u6700\u521d\u7684\u5b66\u4e60\u4e2d\uff0c\u6211\u4eec\u4f1a\u4e3a\u65b0 DM \u5206\u914d\u4e00\u4f4d\u5bfc\u5e08\uff0c\u5728\u81f3\u5c11\u516d\u4e2a\u6708\u7684\u65f6\u95f4\u5185\uff0c\u9ad8\u7ea7 DM \u5c06\u4e3a\u5176\u63d0\u4f9b\u6307\u5bfc\u3002\u6b63\u5982\u6a1f\u5b9c\u673a\u573a\u4e0e\u5404\u822a\u7a7a\u516c\u53f8\u5b9a\u5236\u89e3\u51b3\u65b9\u6848\u548c\u5408\u4f5c\u5173\u7cfb\uff0c\u6211\u4eec\u4e5f\u4e0e\u5ba2\u6237\u8fdb\u884c\u8be6\u7ec6\u8ba8\u8bba\uff0c\u6839\u636e\u5ba2\u6237\u7684\u7814\u7a76\u9700\u6c42\u5b9a\u5236\u7cfb\u7edf\uff0c\u800c\u4e0d\u662f\u4f7f\u7528\u901a\u7528\u7684\u89e3\u51b3\u65b9\u6848\u3002<\/p>\n\n\n\n<p>\u4e0e\u5ba2\u6237\u56e2\u961f\u8ba8\u8bba\u76f8\u5173\u8981\u6c42\u540e\uff0c\u4f1a\u5bf9\u8bbe\u8ba1\u8fdb\u884c\u4e24\u8f6e\u5ba1\u67e5\u2014\u2014\u4e00\u8f6e\u662f\u5bf9\u5c0f\u7ec4\u8d1f\u8d23\u4eba (GL) \u548c\u6280\u672f\u670d\u52a1\u8d1f\u8d23\u4eba (TSL) \u8fdb\u884c\u8981\u6c42\u5c55\u793a\uff0c\u53e6\u4e00\u8f6e\u662f\u8be6\u7ec6\u7684\u8981\u6c42\u5ba1\u67e5\u3002\u5982\u679c\u4efb\u4f55\u8981\u6c42\u6ca1\u6709\u8fbe\u5230\u6807\u51c6\uff0c\u7cfb\u7edf\u8bbe\u8ba1\u7ecf\u7406\u5fc5\u987b\u6839\u636e\u5ba1\u67e5\u8005\u7684\u610f\u89c1\u505a\u51fa\u6539\u8fdb\u3002\u7531\u4e8e\u4e25\u683c\u7684\u8d28\u91cf\u63a7\u5236\uff0c\u8fd9\u610f\u5473\u7740\u9700\u8981\u5728\u77ed\u65f6\u95f4\u5185\u5b8c\u6210\u5927\u91cf\u5de5\u4f5c\u3002\u6211\u56e0\u4e3a\u8fd9\u4e9b\u9ad8\u8981\u6c42\u727a\u7272\u8fc7\u4e00\u4e9b\u7761\u7720\u65f6\u95f4\u3002\u4f46\u662f\uff0c\u8fd9\u662f\u4e3a\u4e86\u786e\u4fdd\u8bbe\u8ba1\u5728\u5ba2\u6237\u7b7e\u7f72\u786e\u8ba4\u4e4b\u524d\u8fbe\u5230\u6700\u9ad8\u8d28\u91cf\u3002<\/p>\n\n\n\n<p><strong>\u4e0d\u4ec5\u662f\u5e38\u89c4\u7684\u9879\u76ee\u7ecf\u7406<\/strong><\/p>\n\n\n\n<p>\u5f53\u4e9a\u592a\u56e2\u961f\u521a\u521a\u8d77\u6b65\u65f6\uff0c\u6211\u4eec DM \u8fd8\u540c\u65f6\u517c\u4efb\u9879\u76ee\u7ecf\u7406 (PM) \u7684\u89d2\u8272\u3002\u6211\u4eec\u7ecf\u5e38\u5f00\u73a9\u7b11\u8bf4\uff0c\u9879\u76ee\u7ecf\u7406\u662f\u6211\u4eec\u7684\u7b2c\u4e00\u9053\u4e5f\u662f\u6700\u540e\u4e00\u9053\u9632\u7ebf\u3002\u6211\u4eec\u662f\u7b2c\u4e00\u4e2a\u6536\u5230\u5ba2\u6237\u8981\u6c42\u7684\u4eba\uff08\u5076\u5c14\u662f\u5f88\u68d8\u624b\u7684\u8981\u6c42\uff09\uff0c\u4e5f\u662f\u6700\u540e\u4e00\u4e2a\u4eab\u53d7\u5de5\u4f5c\u6210\u679c\u7684\u4eba\u3002PM \u5c06\u56e2\u961f\u51dd\u805a\u5728\u4e00\u8d77\uff0c\u786e\u4fdd\u53ca\u65f6\u89e3\u51b3\u51fa\u73b0\u7684\u95ee\u9898\uff0c\u628a\u63a7\u65f6\u95f4\u7ebf\u5e76\u8ba9\u5ba2\u6237\u6ee1\u610f\u3002<\/p>\n\n\n\n<p>PM\u9700\u8981\u7406\u89e3\u5ba2\u6237\u5728\u6c9f\u901a\u4e2d\u63d0\u51fa\u7684\u660e\u786e\u9700\u6c42\uff0c\u4e5f\u9700\u8981\u4e00\u5b9a\u7684\u6280\u80fd\u6765\u63e3\u6469\u5ba2\u6237\u6587\u5b57\u80cc\u540e\u66f4\u6df1\u5c42\u6b21\u7684\u5176\u4ed6\u9700\u6c42\u3002\u6211\u4eec\u7684 PM \u62e5\u6709\u591a\u5e74\u7684\u7ecf\u9a8c\uff0c\u64c5\u957f\u5ba2\u6237\u7ba1\u7406\u3002\u4ed6\u4eec\u4e0e\u7814\u7a76\u56e2\u961f\u6784\u5efa\u4e86\u826f\u597d\u7684\u5408\u4f5c\u5173\u7cfb\uff0c\u6709\u624e\u5b9e\u7684 IXRS \u6280\u672f\u77e5\u8bc6\u3002\u591a\u5e74\u524d\uff0c\u6211\u4ee3\u8868 IXRS \u90e8\u95e8\u51fa\u5e2d\u5728\u4e2d\u56fd\u4e3e\u529e\u7684\u4e00\u573a\u7814\u7a76\u8005\u4f1a\u8bae\uff0c\u5728\u95ee\u7b54\u73af\u8282\uff0c\u4e0e\u4f1a\u8005\u63d0\u51fa\u4e86\u4e00\u4e2a\u4e0e\u836f\u7269\u4f9b\u5e94\u76f8\u5173\u7684\u95ee\u9898\u3002\u5f53\u6211\u56de\u7b54\u95ee\u9898\u65f6\uff0c\u6211\u63d0\u5230\u4e86\u5ba2\u6237\u7684\u5185\u90e8\u6807\u51c6\uff0c\u8fd9\u5e76\u4e0d\u5c5e\u4e8e IXRS \u8303\u56f4\u3002\u5348\u9910\u65f6\uff0c\u5ba2\u6237\u7684\u7814\u7a76\u7ecf\u7406\u5bf9\u6211\u8bf4\uff0cAlmac PM \u80fd\u5411\u4e0e\u4f1a\u8005\u63d0\u4f9b\u5982\u6b64\u8be6\u5c3d\u7684\u56de\u7b54\uff0c\u4ee4\u4ed6\u5370\u8c61\u6df1\u523b\u3002<\/p>\n\n\n\n<p><strong>\u5f00\u53d1\u548c\u6d4b\u8bd5\u4e2d\u7684\u5408\u4f5c\u4e0e\u652f\u6301<\/strong><\/p>\n\n\n\n<p>\u5728\u4e0e\u5f00\u53d1\u56e2\u961f\u4ea4\u6d41\u65f6\uff0c\u4ed6\u4eec\u5e38\u8bf4\u5728 Almac\uff0c\u5f00\u53d1\u4ece\u6765\u90fd\u4e0d\u662f\u4e00\u4e2a\u4eba\u7684\u6218\u6597\u3002\u6bcf\u4e2a\u9879\u76ee\u4f0a\u59cb\uff0c\u90fd\u4f1a\u914d\u5907\u6280\u672f\u670d\u52a1\u8d1f\u8d23\u4eba (TSL) \u63d0\u4f9b\u4e13\u4e1a\u652f\u6301\u548c\u6280\u672f\u6307\u5bfc\u3002TSL \u4e0d\u4ec5\u53c2\u4e0e\u65e5\u5e38\u54a8\u8be2\uff0c\u8fd8\u4f1a\u5bf9\u4ee3\u7801\u8fdb\u884c\u4e25\u683c\u5ba1\u67e5\uff0c\u7279\u522b\u662f\u786e\u4fdd\u90a3\u4e9b\u590d\u6742\u5ea6\u9ad8\u3001\u98ce\u9669\u7b49\u7ea7\u5927\u7684\u6a21\u5757\u5f97\u5230\u6700\u4f18\u5316\u5904\u7406\u3002\u6211\u4eec\u7684\u6d4b\u8bd5\u4eba\u5458\u5bf9\u8fd9\u4e9b\u4ee3\u7801\u8fdb\u884c\u4e86\u5927\u91cf\u6d4b\u8bd5\uff0c\u516c\u53f8\u4e5f\u4e3a\u6b64\u5206\u914d\u4e86\u4e00\u4f4d GL \u63d0\u4f9b\u652f\u6301\u548c\u54a8\u8be2\u3002\u672a\u901a\u8fc7\u6d4b\u8bd5\u7684\u7279\u6027\u5c06\u901a\u8fc7\u9002\u5f53\u7684\u7cfb\u7edf\u63d0\u51fa\u7f3a\u9677\uff0c\u786e\u4fdd\u5f97\u5230\u89e3\u51b3\u3002\u5728\u5f00\u53d1\u548c\u6d4b\u8bd5\u671f\u95f4\uff0c\u6211\u4eec DM\u3001\u5f00\u53d1\u4eba\u5458\u548c\u6d4b\u8bd5\u4eba\u5458\u4e0d\u65ad\u6c9f\u901a\uff0c\u89e3\u51b3\u95ee\u9898\u6216\u8fdb\u884c\u8bbe\u8ba1\u6240\u9700\u7684\u6539\u8fdb\u3002<\/p>\n\n\n\n<p>\u5e78\u8fd0\u7684\u662f\uff0c\u516b\u5e74\u6765\uff0c\u6211\u53ea\u9047\u5230\u8fc7\u5c11\u6570\u6781\u4e3a\u590d\u6742\u7684\u7814\u7a76\u3002\u6211\u8bb0\u5f97\u5176\u4e2d\u4e00\u9879\u7814\u7a76\u6d89\u53ca\u5316\u7597\uff0c\u5176\u4e2d\u6709\u591a\u4e2a\u5242\u91cf\u8c03\u6574\u89c4\u5b9a\u548c\u4e0d\u540c\u7684\u5316\u7597\u65b9\u6848\u7ec4\u5408\uff0c\u4f1a\u5bf9\u8bbf\u89c6\u65f6\u95f4\u8868\u4ea7\u751f\u5f71\u54cd\u3002\u6211\u4eec\u9762\u4e34\u7684\u6311\u6218\u662f\uff0c\u9700\u8981\u628a\u8fd9\u4e2a\u9ad8\u5ea6\u590d\u6742\u7684\u7814\u7a76\u8bbe\u8ba1\u5f97\u6613\u4e8e\u7814\u7a76\u4e2d\u5fc3\u7528\u6237\u5bfc\u822a\u548c\u64cd\u4f5c\u3002\u5728\u7814\u7a76\u5f00\u53d1\u671f\u95f4\uff0c\u5f00\u53d1\u4eba\u5458\u9700\u8981\u63a2\u7d22\u4e0d\u540c\u7684\u7f16\u7801\u65b9\u5f0f\uff0c\u786e\u4fdd\u7cfb\u7edf\u80fd\u9488\u5bf9\u4e0d\u540c\u7684\u5316\u7597\u5207\u6362\u8bbf\u89c6\u65f6\u95f4\u8868\u3002\u6211\u4eec\u8fd8\u805a\u5728\u4e00\u8d77\u8ba8\u8bba\u4e0d\u540c\u7684\u6d4b\u8bd5\u573a\u666f\u5e76\u5bf9\u8bbe\u8ba1\u505a\u51fa\u76f8\u5e94\u8c03\u6574\uff0c\u786e\u4fdd\u7cfb\u7edf\u6ca1\u6709\u6f0f\u6d1e\u3002\u50cf\u6a1f\u5b9c\u673a\u573a\u4e00\u6837\uff0c\u6211\u4eec\u4e5f\u60f3\u8d85\u8d8a\u5ba2\u6237\u7684\u671f\u5f85\uff0c\u4e3a\u4ed6\u4eec\u63d0\u4f9b\u8f7b\u677e\u6109\u5feb\u7684\u7cfb\u7edf\u4f7f\u7528\u4f53\u9a8c\u3002<\/p>\n\n\n\n<p><strong>\u8d28\u91cf\u4fdd\u8bc1\uff1a\u4e0d\u80fd\u901a\u8fc7\uff1f<\/strong><\/p>\n\n\n\n<p>\u7cfb\u7edf\u6b63\u5f0f\u4e0a\u7ebf\u524d\uff0c\u5373\u4fbf\u5df2\u5b8c\u6210\u5168\u90e8\u5f00\u53d1\u5de5\u4f5c\u3001\u5185\u90e8\u6d4b\u8bd5\u548c\u7528\u6237\u9a8c\u6536\u6d4b\u8bd5 (UAT)\uff0c\u8fd8\u9700\u7ecf\u8fc7\u6211\u4eec\u4e25\u8c28\u7684\u8d28\u91cf\u4fdd\u8bc1\u5206\u6790\u5458 (QA) \u56e2\u961f\u628a\u5173\u3002QA \u56e2\u961f\u606a\u5b88\u8d28\u91cf\u51c6\u5219\uff0c\u4e25\u683c\u5ba1\u6838\u6240\u6709\u6587\u6863\u3001\u5f00\u53d1\u4efb\u52a1\u548c\u6d4b\u8bd5\u7528\u4f8b\uff0c\u786e\u4fdd\u6bcf\u4e00\u4e2a\u73af\u8282\u90fd\u8fbe\u5230\u8d28\u91cf\u63a7\u5236\u7684\u6700\u9ad8\u6807\u51c6\u3002\u5982\u6709\u4efb\u4f55\u504f\u5dee\uff0c\u7cfb\u7edf\u90fd\u65e0\u6cd5\u901a\u8fc7\u8fd9\u9053\u4e25\u683c\u7684\u8d28\u91cf\u68c0\u9a8c\u3002<\/p>\n\n\n\n<p>\u6211\u4eec\u7684 QA \u56e2\u961f\u4e0d\u4ec5\u4e3a\u6211\u4eec\u7684\u5f00\u53d1\u62c5\u4efb\u628a\u5173\u8005\uff0c\u6211\u4eec\u8fd8\u6709\u4e00\u652f\u4e8b\u4ef6\u62a5\u544a (IR) \u56e2\u961f\uff0c\u4f1a\u4e00\u4e1d\u4e0d\u82df\u5730\u8c03\u67e5\u4efb\u4f55\u8d28\u91cf\u4e8b\u4ef6\uff0c\u5bf9\u539f\u56e0\u63d0\u4f9b\u8be6\u7ec6\u62a5\u544a\u5e76\u5236\u5b9a\u7ea0\u6b63\u548c\u9884\u9632\u63aa\u65bd (CAPA)\u3002\u4ed6\u4eec\u7684\u5de5\u4f5c\u5e2e\u52a9\u6211\u4eec\u4e0d\u65ad\u8bc6\u522b\u7f3a\u9677\uff0c\u6539\u8fdb\u6211\u4eec\u7684\u6d41\u7a0b\u3002<\/p>\n\n\n\n<p>\u5f53\u7136\uff0c\u6211\u4eec\u5fc5\u987b\u627f\u8ba4\u6211\u4eec\u7684\u5ba1\u8ba1\u56e2\u961f\u5728\u652f\u6301\u5ba1\u8ba1\u548c\u68c0\u67e5\u65b9\u9762\u53d1\u6325\u4e86\u5173\u952e\u4f5c\u7528\u3002\u6211\u4eec\u7684\u5ba1\u8ba1\u56e2\u961f\u7531\u7cbe\u4e13\u4eba\u624d\u7ec4\u6210\uff0c\u53ef\u4ee5\u534f\u8c03\u6240\u6709\u6587\u4ef6\u548c\u9762\u8bd5\u8981\u6c42\u2014\u2014\u65e0\u8bba\u662f\u5e38\u89c4\u5ba1\u8ba1\u8fd8\u662f\u5ba2\u6237\u8981\u6c42\u7684\u5ba1\u8ba1\u3002\u4ed6\u4eec\u786e\u4fdd\u987a\u5229\u8fdb\u884c\u5ba1\u8ba1\u68c0\u67e5\uff0c\u51c6\u786e\u63d0\u4f9b\u6587\u4ef6\uff0c\u4ed4\u7ec6\u8ddf\u8e2a\u548c\u8bb0\u5f55\u6240\u6709\u8981\u6c42\u3002\u4ed6\u4eec\u5e2e\u52a9\u6211\u4eec\u4e0e\u65f6\u4ff1\u8fdb\uff0c\u9075\u5b88\u81f3\u5173\u91cd\u8981\u7684\u76d1\u7ba1\u6307\u5357\u3002<\/p>\n\n\n\n<p><strong>\u6211\u4eec\u7684\u56e2\u961f\u6210\u529f\u6848\u4f8b<\/strong><strong> 1<\/strong><\/p>\n\n\n\n<p>2020 \u5e74\u65b0\u51a0\u75ab\u60c5\u7206\u53d1\uff0c\u4e2d\u56fd\u5404\u5730\u5b9e\u65bd\u4e25\u683c\u7684\u75ab\u60c5\u7ba1\u63a7\u63aa\u65bd\uff0c\u533b\u9662\u5f88\u96be\u5411\u60a3\u8005\u63d0\u4f9b\u836f\u7269\uff0c\u60a3\u8005\u4e5f\u96be\u4ee5\u8fdb\u5165\u533b\u9662\u3002\u8fd9\u7ed9\u6211\u4eec\u5728\u4e2d\u56fd\u6b63\u5728\u8fdb\u884c\u7684\u591a\u9879\u4e34\u5e8a\u7814\u7a76\u5e26\u6765\u4e86\u524d\u6240\u672a\u6709\u7684\u6311\u6218\u3002\u6211\u4eec\u7684\u4e00\u4f4d\u5ba2\u6237\u8054\u7cfb\u5230\u6211\u4eec\u7684\u9879\u76ee\u7ecf\u7406 (PM)\uff0c\u5bfb\u6c42\u5e94\u5bf9\u8fd9\u79cd\u7279\u6b8a\u60c5\u51b5\u7684\u610f\u89c1\u6216\u89e3\u51b3\u65b9\u6848\u3002\u8fd9\u4f4d PM \u7ec4\u7ec7\u4e86\u4e00\u573a\u5ba2\u6237\u4f1a\u8bae\uff0c\u5e76\u8bf7\u4e00\u4f4d\u7cfb\u7edf\u8bbe\u8ba1\u7ecf\u7406\u4f5c\u4e3a\u987e\u95ee\u6765\u8ba8\u8bba\u6f5c\u5728\u7684\u89e3\u51b3\u65b9\u6848\u3002<\/p>\n\n\n\n<p>\u8ba8\u8bba\u5f97\u51fa\u7684\u7ed3\u8bba\u662f\uff0c\u5c31\u5ba2\u6237\u5f00\u5c55\u7814\u7a76\u800c\u8a00\uff0c\u552f\u4e00\u53ef\u884c\u7684\u9009\u62e9\u662f\u5c06\u836f\u7269\u76f4\u63a5\u4ece\u4ed3\u5e93\u5bc4\u7ed9\u60a3\u8005\u3002\u4e00\u4e9b\u7814\u7a76\u66f4\u4e3a\u590d\u6742\uff0c\u5c24\u5176\u662f\u6d89\u53ca\u7f16\u53f7\u836f\u76d2\u7684\u53cc\u76f2\u7814\u7a76\u3002\u5e78\u8fd0\u7684\u662f\uff0c\u6211\u4eec\u521a\u624d\u63d0\u5230\u7684\u8fd9\u9879\u7814\u7a76\u662f\u5f00\u653e\u6027 (OL) \u7814\u7a76\uff0c\u65e0\u9700\u5bf9\u836f\u76d2\u8fdb\u884c\u7f16\u53f7\uff0c\u56e0\u6b64\u6211\u4eec\u53ef\u4ee5\u5feb\u901f\u8bbe\u8ba1\u51fa\u5e94\u5bf9\u65b9\u6cd5\u3002\u8fd9\u4e00\u8fc7\u7a0b\u6d89\u53ca\u836f\u7269\u4f9b\u5e94\u7ba1\u7406\u8005\u4f7f\u7528\u8c03\u6574\u5e93\u5b58\u529f\u80fd\uff0c\u5c06\u836f\u7269\u4ece\u4ed3\u5e93\u9001\u5f80\u7814\u7a76\u4e2d\u5fc3\u3002\u7136\u540e\u7814\u7a76\u4e2d\u5fc3\u4e3a\u53d7\u8bd5\u8005\u8fdb\u884c\u8bbf\u89c6\u64cd\u4f5c\u3002\u5b8c\u6210\u4e4b\u540e\uff0c\u7814\u7a76\u4e2d\u5fc3\u5c06\u8058\u7528\u4e13\u4e1a\u7684\u4e34\u5e8a\u7269\u6d41\u516c\u53f8\u5c06\u7814\u7a76\u836f\u7269\u76f4\u63a5\u4ece\u4ed3\u5e93\u9001\u8fbe\u53d7\u8bd5\u8005\u3002\u4f7f\u7528\u6b64\u65b9\u6cd5\uff0c\u6211\u4eec\u786e\u4fdd\u60a3\u8005\u53ef\u4ee5\u7ee7\u7eed\u7528\u836f\uff0c\u7814\u7a76\u987a\u5229\u5f00\u5c55\uff0c\u6ca1\u6709\u518d\u88ab\u4e2d\u65ad\u3002<\/p>\n\n\n\n<p>\u867d\u7136\u5e94\u5bf9\u65b9\u6cd5\u5f88\u7b80\u5355\uff0c\u4f46\u662f\u8fd9\u573a\u4f1a\u8bae\u6301\u7eed\u4e00\u5c0f\u65f6\uff0c\u56e0\u4e3a\u6211\u4eec\u9700\u8981\u4e86\u89e3\u5ba2\u6237\u7684\u8fd0\u8425\u9650\u5236\uff0c\u4ece\u800c\u63d0\u4f9b\u517c\u987e\u5ba2\u6237\u548c\u60a3\u8005\u7684\u4f18\u9009\u89e3\u51b3\u65b9\u6848\u3002\u6b64\u6b21\u75ab\u60c5\u89c4\u6a21\u5bf9\u4e8e\u5927\u5bb6\u6765\u8bf4\u524d\u6240\u672a\u6709\u3002\u7136\u800c\uff0c\u6211\u4eec\u5c06\u6b64\u6b21\u7ecf\u5386\u4f5c\u4e3a\u5b66\u4e60\u673a\u4f1a\uff0c\u65b0\u589e\u201c\u4ed3\u5e93\u76f4\u8fbe\u53d7\u8bd5\u8005\u8bbf\u89c6\u5206\u914d\u201d\u529f\u80fd\uff0c\u589e\u5f3a\u4e86\u6211\u4eec\u7684\u7cfb\u7edf\u3002<\/p>\n\n\n\n<p><strong>\u6211\u4eec\u7684\u56e2\u961f\u6210\u529f\u6848\u4f8b<\/strong><strong> 2<\/strong><\/p>\n\n\n\n<p>\u5f88\u591a\u5e74\u524d\u5728\u6211\u4eec\u7684\u4e00\u9879\u7814\u7a76\u4e2d\uff0c\u4e00\u79cd\u836f\u76d2\u7c7b\u578b\u88ab\u66ff\u6362\u4e86\uff0c\u4f46\u662f\u6ca1\u6709\u5f15\u8d77 IRT \u9879\u76ee\u7ecf\u7406\u7684\u6ce8\u610f\u3002\u65b0\u7684\u836f\u76d2\u7c7b\u578b\u4f53\u79ef\u6709\u53d8\uff0c\u5f71\u54cd\u4e86\u5b9e\u9645\u5206\u914d\u7684\u836f\u91cf\u3002\u8fd9\u9700\u8981\u7cfb\u7edf\u5206\u914d\u65b0\u7684\u836f\u76d2\u7c7b\u578b\u4ee3\u7801\u548c\u7cfb\u7edf\u4fee\u6539\uff0c\u6765\u66f4\u65b0\u836f\u76d2\u5206\u914d\u903b\u8f91\u3002\u5f53\u65f6\u6709\u4e94\u516d\u540d\u60a3\u8005\u6b63\u5728\u7b49\u5f85\u968f\u673a\u5206\u914d\uff0c\u800c\u56e0\u4e3a\u65b0\u7684\u836f\u76d2\u7c7b\u578b\u65e0\u6cd5\u5206\u914d\u5bfc\u81f4\u64cd\u4f5c\u65e0\u6cd5\u8fdb\u884c\uff0c\u8ba9\u60c5\u51b5\u53d8\u5f97\u5f88\u590d\u6742\u3002\u7531\u4e8e\u6b64\u7814\u7a76\u62db\u52df\u60a3\u8005\u5f88\u96be\uff0c\u56e0\u6b64\u5ba2\u6237\u7aed\u529b\u907f\u514d\u60a3\u8005\u6d41\u5931\u3002<\/p>\n\n\n\n<p>\u6211\u4eec\u7684 PM \u4e0e\u5ba2\u6237\u53ec\u5f00\u4e86\u4f1a\u8bae\uff0c\u6211\u4eec\u7684\u56e2\u961f\u5f00\u59cb\u7814\u7a76\u89e3\u51b3\u65b9\u6848\u3002\u901a\u8fc7\u53c2\u9605\u7814\u7a76\u968f\u673a\u5206\u914d\u8bb0\u5f55\uff0c\u6211\u4eec\u5236\u5b9a\u4e86\u5e94\u5bf9\u65b9\u6cd5\uff0c\u8ba9\u53d7\u8bd5\u8005\u5b8c\u6210\u968f\u673a\u5206\u914d\uff0c\u76f4\u5230\u7cfb\u7edf\u53ef\u4ee5\u66f4\u65b0\u3002\u6211\u4eec\u8fd8\u4e0e\u5ba2\u6237\u7684\u836f\u7269\u4f9b\u5e94\u7ecf\u7406\u8bc4\u4f30\u540e\u7eed\u53ef\u80fd\u53d7\u5230\u5f71\u54cd\u7684\u836f\u7269\u5206\u53d1\uff0c\u5e76\u627e\u5230\u7f13\u89e3\u65b9\u6cd5\uff0c\u907f\u514d\u5f71\u54cd\u53d7\u8bd5\u8005\u6cbb\u7597\u3002\u6211\u4eec\u7684 QA \u56e2\u961f\u786e\u4fdd\u8fd9\u4e9b\u6d41\u7a0b\u548c\u504f\u79bb\u5f97\u5230\u59a5\u5584\u8bb0\u5f55\u3001\u5b58\u6863\u5e76\u89e3\u51b3\u4efb\u4f55\u6f5c\u5728\u7684\u76d1\u7ba1\u95ee\u9898\u3002\u8fd9\u6837\uff0c\u5373\u4f7f\u9762\u4e34\u7a3d\u67e5\u68c0\u67e5\uff0c\u6211\u4eec\u4e5f\u6709\u628a\u63e1\u786e\u4fdd\u6d41\u7a0b\u4e0d\u4f1a\u7834\u574f\u7814\u7a76\u7684\u5b8c\u6574\u6027\u3002<\/p>\n\n\n\n<p>\u5728\u8fd9\u4e9b\u6d41\u7a0b\u8fdb\u884c\u671f\u95f4\uff0c\u6211\u4eec\u4f1a\u5feb\u901f\u7ec4\u5efa\u4e00\u4e2a\u56e2\u961f\u8fdb\u884c\u7d27\u6025\u7248\u672c\u53d1\u5e03\uff0c\u4e89\u5206\u593a\u79d2\u5730\u5de5\u4f5c\u3002\u53d1\u5e03\u7248\u672c\u4e0a\u7ebf\u540e\uff0c\u5411 IXRS \u4e2d\u8f93\u5165\u6b63\u786e\u6570\u636e\uff0c\u5339\u914d\u6240\u6709\u64cd\u4f5c\u3002\u6dfb\u52a0\u65b0\u836f\u76d2\u7c7b\u578b\u5206\u914d\u903b\u8f91\u548c\u7248\u672c\u4e0a\u7ebf\u7684\u6574\u4e2a\u6d41\u7a0b\u7528\u65f6\u4e0d\u5230\u4e00\u5468\uff0c\u8d28\u91cf\u6ca1\u6709\u53d7\u5230\u5f71\u54cd\u3002\u6240\u6709\u53d7\u8bd5\u8005\u90fd\u63a5\u53d7\u4e86\u6b63\u786e\u6cbb\u7597\uff0c\u7ef4\u62a4\u4e86\u6570\u636e\u5b8c\u6574\u6027\uff0c\u62db\u52df\u5de5\u4f5c\u6ca1\u6709\u53d7\u5230\u5f71\u54cd\uff0c\u6240\u6709\u63ed\u76f2\u4fe1\u606f\u90fd\u5f97\u5230\u4e86\u5b89\u5168\u4fdd\u62a4\u3002\u867d\u7136\u6211\u4eec\u5e76\u6ca1\u6709\u8ba4\u4e3a\u81ea\u5df1\u662f\u8d85\u7ea7\u82f1\u96c4\uff0c\u4f46\u5728\u90a3\u4e00\u5468\uff0c\u6211\u4eec\u4e2d\u7684\u5f88\u591a\u4eba\u90fd\u611f\u89c9\u81ea\u5df1\u8eab\u62ab\u62ef\u6551\u7814\u7a76\u7684\u6597\u7bf7\u3002<\/p>\n\n\n\n<p><strong>\u7ed3\u8bba<\/strong><\/p>\n\n\n\n<p>\u6700\u540e\uff0c\u6211\u60f3\u5206\u4eab\u6765\u81ea\u51e0\u4f4d\u5ba2\u6237\u7814\u7a76\u7ecf\u7406\u7684\u4e00\u4e9b\u8bc4\u4ef7\uff1a<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>\u201c\u4e0e\u5176\u4ed6\u4f9b\u5e94\u5546\u76f8\u6bd4\uff0c\u6211\u4eec\u611f\u89c9\u628a\u7814\u7a76\u4ea4\u7ed9 Almac \u66f4\u8ba9\u4eba\u653e\u5fc3\u3002\u201d<\/em><\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>\u201cAlmac \u5bf9\u6211\u4eec\u5185\u90e8\u6d41\u7a0b\u7684\u4e86\u89e3\u7740\u5b9e\u8ba9\u6211\u60ca\u559c\u3002\u8fd9\u4e5f\u5c55\u73b0\u4e86 Almac \u7684\u54c1\u8d28\u3002\u201d<\/em><\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><em>\u201c\u4f7f\u7528 Almac IRT \u5f00\u5c55\u7684\u4efb\u4f55\u7814\u7a76\u90fd\u4e0d\u7528\u62c5\u5fc3\u3002\u4e0e\u5176\u4ed6\u4f9b\u5e94\u5546\u76f8\u6bd4\uff0cAlmac \u7684 UAT \u5c24\u4e3a\u987a\u7545\u3002\u201d<\/em><\/li>\n<\/ul>\n\n\n\n<p>\u8fd9\u4e9b\u8bc4\u4ef7\u6765\u81ea\u6211\u4eec\u7684\u91cd\u8981\u5ba2\u6237\uff0c\u5bf9\u6211\u4eec\u800c\u8a00\u662f\u83ab\u5927\u7684\u9f13\u52b1\u3002\u6a1f\u5b9c\u673a\u573a\u548c Almac \u7684\u6210\u529f\u90fd\u6e90\u4e8e\u5bf9\u8d28\u91cf\u548c\u4e0d\u65ad\u63d0\u5347\u7684\u8ffd\u6c42\u3002\u5982\u540c\u6a1f\u5b9c\u673a\u573a\u5728\u822a\u7a7a\u4e1a\u7684\u5353\u8d8a\u8868\u73b0\uff0cAlmac \u5bf9\u5f00\u53d1\u6d41\u7a0b\u7684\u72ec\u7279\u65b9\u6cd5\u786e\u4fdd\u6211\u4eec\u63d0\u4f9b\u53ef\u9760\u7684 IRT \u89e3\u51b3\u65b9\u6848\u3002<\/p>\n\n\n\n<p>\u6211\u4eec\u6d41\u7a0b\u7684\u4e0d\u540c\u4e4b\u5904\u5728\u4e8e\u6211\u4eec\u7ec6\u81f4\u4e86\u89e3\u5ba2\u6237\u9700\u6c42\uff0c\u4e25\u683c\u6267\u884c\u8d28\u91cf\u63a7\u5236\uff0c\u8df5\u884c\u5f00\u8bda\u5e03\u516c\u548c\u4e0d\u65ad\u5b66\u4e60\u7684\u6587\u5316\u3002\u8fd9\u4e9b\u72ec\u7279\u5143\u7d20\u662f\u6211\u4eec\u5f00\u5c55\u4e1a\u52a1\u7684\u5fc5\u8981\u90e8\u5206\uff0c\u4e3a\u6211\u4eec\u8d62\u5f97\u4e86\u5ba2\u6237\u7684\u4fe1\u4efb\u4e0e\u5fe0\u8bda\u3002\u968f\u7740\u6211\u4eec\u4e0d\u65ad\u521b\u65b0\u5e76\u575a\u6301\u8fd9\u4e9b\u9ad8\u6807\u51c6\uff0c\u6211\u4eec\u76f8\u4fe1\u81ea\u5df1\u80fd\u591f\u63d0\u4f9b\u5353\u8d8a\u7684\u670d\u52a1\u5e76\u4fdd\u6301\u6211\u4eec\u5728\u884c\u4e1a\u5185\u7684\u9886\u5bfc\u5730\u4f4d\u3002<\/p>\n\n\n\n<p>\u5982\u9700\u8be6\u7ec6\u4e86\u89e3 Almac \u5728\u4e9a\u592a\u5730\u533a\u7684 IRT \u80fd\u529b\u4ee5\u53ca\u6211\u4eec\u81f4\u529b\u4e8e\u4e3a\u5ba2\u6237\u63d0\u4f9b\u4f18\u8d28\u670d\u52a1\u7684\u627f\u8bfa\uff0c\u8bf7\u8bbf\u95ee\u6211\u4eec\u7684\u7f51\u7ad9\uff1aAlmac \u5728\u4e9a\u592a\u533a\u7684\u5353\u8d8a\u6210\u5c31\u4e0e\u6218\u7565\u90e8\u7f72<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u9769\u65b0\u7684 IRT \u89e3\u51b3\u65b9\u6848\uff1aAlmac \u5bf9\u5728\u4e9a\u592a\u5730\u533a\u4e34\u5e8a\u5b9e\u9a8c\u8d28\u91cf\u4e0e\u521b\u65b0\u7684\u627f\u8bfa Joseph Goh &#8211; Design Manager &#8211; \u7cfb\u7edf\u8bbe\u8ba1\u7ecf\u7406 | Almac Clinical Technologies \u7b80\u4ecb \u6211\u662f Joseph\uff0c\u5728 Almac \u62c5\u4efb\u7cfb\u7edf\u8bbe\u8ba1\u7ecf\u7406\u8fd1\u516b\u5e74\u3002\u6211\u6765\u81ea\u65b0\u52a0\u5761\uff0c\u5e76\u5728\u6b64\u5f00\u542f\u4e86\u6211\u7684\u804c\u4e1a\u751f\u6daf\uff0c\u4f46\u6211\u73b0\u5728\u5df2\u5728\u65e5\u672c\u5de5\u4f5c\u8d85\u8fc7\u4e24\u5e74\u3002 \u6a1f\u5b9c\u673a\u573a\u6210\u529f\u80cc\u540e\u7684\u79d8\u5bc6 \u4f5c\u4e3a\u4e00\u540d\u65b0\u52a0\u5761\u4eba\uff0c\u6211\u4e3a\u6211\u4eec\u7684\u6a1f\u5b9c\u56fd\u9645\u673a\u573a\u6df1\u611f\u81ea\u8c6a\u3002\u6a1f\u5b9c\u673a\u573a\u4e8e2013 \u81f3 2020 \u5e74\u8fde\u7eed\u516b\u5e74\u8749\u8054\u5168\u7403\u6700\u4f73\u673a\u573a\uff0c\u517112\u6b21\u8363\u81ba\u6842\u51a0\u3002\u8fd9\u4efd\u9a84\u4eba\u6210\u7ee9\u7684\u80cc\u540e\uff0c\u662f\u5bf9\u4ee5\u6d41\u7a0b\u4e3a\u5bfc\u5411\u7684\u9ad8\u54c1\u8d28\u670d\u52a1\u7684\u575a\u6301\u3002\u4f8b\u5982\uff0c\u6a1f\u5b9c\u673a\u573a\u4e0e\u5404\u822a\u7a7a\u516c\u53f8\u5b9a\u5236\u89e3\u51b3\u65b9\u6848\u548c\u5408\u4f5c\u4f19\u4f34\u5173\u7cfb\uff0c\u800c\u975e\u4f7f\u7528\u901a\u7528\u6a21\u5f0f\u3002\u8fd9\u6709\u52a9\u4e8e\u6a1f\u5b9c\u673a\u573a\u63a8\u52a8\u822a\u7a7a\u4ea4\u901a\u548c\u8fde\u901a\u6027\uff0c\u4fdd\u6301\u5176\u4e00\u6d41\u822a\u7a7a\u67a2\u7ebd\u7684\u5730\u4f4d\u3002\u673a\u573a\u7684\u613f\u666f\u5305\u62ec\u63d0\u4f9b\u72ec\u5230\u7684\u6a1f\u5b9c\u4f53\u9a8c\u2014\u2014\u6253\u9020\u4e2a\u6027\u5316\u3001\u8f7b\u677e\u65e0\u5fe7\u3001\u5145\u6ee1\u60ca\u559c\u7684\u65c5\u7a0b\u3002\u8fd9\u610f\u5473\u7740\u9700\u8981\u4e0d\u65ad\u6539\u8fdb\u3001\u66f4\u65b0\u6216\u65b0\u5efa\u673a\u573a\u8bbe\u65bd\uff0c\u4ece\u800c\u8d85\u8d8a\u5ba2\u6237\u548c\u4e58\u5ba2\u7684\u671f\u5f85\u3002\u6a1f\u5b9c\u673a\u573a\u7684\u5353\u8d8a\u6587\u5316\u4f7f\u5176\u591a\u5e74\u6765\u59cb\u7ec8\u4fdd\u6301\u4e00\u6d41\u673a\u573a\u7684\u5730\u4f4d\u3002\u6211\u4e3e\u8fd9\u4e2a\u4f8b\u5b50\u4e5f\u662f\u4e3a\u4e86\u8bf4\u660e\uff0c\u4e3a\u4ec0\u4e48 Almac \u80fd\u59cb\u7ec8\u4fdd\u6301 IRT \u4f18\u8d28\u4f9b\u5e94\u5546\u7684\u5730\u4f4d\u3002 IRT \u7cfb\u7edf\u7684\u771f\u6b63\u4ef7\u503c \u5f53\u524d\uff0cIRT \u7cfb\u7edf\u4e0d\u65ad\u589e\u52a0\u65b0\u7684\u7279\u6027\u548c\u529f\u80fd\uff0c\u5e76\u62e5\u6709\u7f8e\u8f6e\u7f8e\u5942\u7684\u7528\u6237\u754c\u9762\u3002\u8fd9\u4e9b\u56fa\u7136\u91cd\u8981\uff0c\u7136\u800c\uff0c\u6211\u4eec\u9700\u8981\u601d\u8003\u7684\u662f\uff1a\u7cfb\u7edf\u529f\u80fd\u7a76\u7adf\u53ef\u4ee5\u6269\u5c55\u5230\u4f55\u79cd\u7a0b\u5ea6\uff1fIRT \u4f9b\u5e94\u5546\u63d0\u4f9b\u7684\u6838\u5fc3\u529f\u80fd\u5927\u540c\u5c0f\u5f02\uff0c \u771f\u6b63\u8ba9 Almac \u8131\u9896\u800c\u51fa\uff0c\u533a\u522b\u4e8e\u7ade\u4e89\u5bf9\u624b\u7684\u4e00\u4e2a\u5173\u952e\u56e0\u7d20\u662f\u6211\u4eec\u80fd\u591f\u63d0\u4f9b\u7684\u6d41\u7a0b\u3001\u670d\u52a1\u548c\u6280\u672f\u652f\u6301\u3002 \u8d28\u91cf\u59cb\u4e8e\u8bbe\u8ba1 \u521d\u4efb\u7cfb\u7edf\u8bbe\u8ba1\u7ecf\u7406 (DM) \u65f6\uff0c\u6211\u88ab\u544a\u77e5\u8fd9\u4e2a\u5c97\u4f4d\u9700\u8981\u5b66\u4e60\u76f8\u5f53\u957f\u4e00\u6bb5\u65f6\u95f4\u624d\u80fd\u5b8c\u5168\u80dc\u4efb\uff0c\u56e0\u4e3a\u5b83\u6d89\u53ca\u5468\u5bc6\u7684\u89c4\u5212\u3001\u4e25\u683c\u7684\u8bbe\u8ba1\u6807\u51c6\u4ee5\u53ca\u5168\u65b9\u4f4d\u7684\u8d28\u91cf\u7ba1\u63a7\u3002\u4f5c\u4e3a DM\uff0c\u6211\u4eec\u4e0d\u4ec5\u9700\u8981\u901a\u8fc7\u7cfb\u7edf\u5316\u57f9\u8bad\uff0c\u66f4\u8981\u5177\u5907\u6df1\u5165\u7406\u89e3\u7814\u7a76\u65b9\u6848\u7684\u80fd\u529b\uff0c\u624d\u80fd\u8bbe\u8ba1\u51fa\u6700\u4f18\u7684 IRT \u89e3\u51b3\u65b9\u6848\u3002\u5728\u6700\u521d\u7684\u5b66\u4e60\u4e2d\uff0c\u6211\u4eec\u4f1a\u4e3a\u65b0 DM \u5206\u914d\u4e00\u4f4d\u5bfc\u5e08\uff0c\u5728\u81f3\u5c11\u516d\u4e2a\u6708\u7684\u65f6\u95f4\u5185\uff0c\u9ad8\u7ea7 DM \u5c06\u4e3a\u5176\u63d0\u4f9b\u6307\u5bfc\u3002\u6b63\u5982\u6a1f\u5b9c\u673a\u573a\u4e0e\u5404\u822a\u7a7a\u516c\u53f8\u5b9a\u5236\u89e3\u51b3\u65b9\u6848\u548c\u5408\u4f5c\u5173\u7cfb\uff0c\u6211\u4eec\u4e5f\u4e0e\u5ba2\u6237\u8fdb\u884c\u8be6\u7ec6\u8ba8\u8bba\uff0c\u6839\u636e\u5ba2\u6237\u7684\u7814\u7a76\u9700\u6c42\u5b9a\u5236\u7cfb\u7edf\uff0c\u800c\u4e0d\u662f\u4f7f\u7528\u901a\u7528\u7684\u89e3\u51b3\u65b9\u6848\u3002 \u4e0e\u5ba2\u6237\u56e2\u961f\u8ba8\u8bba\u76f8\u5173\u8981\u6c42\u540e\uff0c\u4f1a\u5bf9\u8bbe\u8ba1\u8fdb\u884c\u4e24\u8f6e\u5ba1\u67e5\u2014\u2014\u4e00\u8f6e\u662f\u5bf9\u5c0f\u7ec4\u8d1f\u8d23\u4eba (GL) \u548c\u6280\u672f\u670d\u52a1\u8d1f\u8d23\u4eba (TSL) \u8fdb\u884c\u8981\u6c42\u5c55\u793a\uff0c\u53e6\u4e00\u8f6e\u662f\u8be6\u7ec6\u7684\u8981\u6c42\u5ba1\u67e5\u3002\u5982\u679c\u4efb\u4f55\u8981\u6c42\u6ca1\u6709\u8fbe\u5230\u6807\u51c6\uff0c\u7cfb\u7edf\u8bbe\u8ba1\u7ecf\u7406\u5fc5\u987b\u6839\u636e\u5ba1\u67e5\u8005\u7684\u610f\u89c1\u505a\u51fa\u6539\u8fdb\u3002\u7531\u4e8e\u4e25\u683c\u7684\u8d28\u91cf\u63a7\u5236\uff0c\u8fd9\u610f\u5473\u7740\u9700\u8981\u5728\u77ed\u65f6\u95f4\u5185\u5b8c\u6210\u5927\u91cf\u5de5\u4f5c\u3002\u6211\u56e0\u4e3a\u8fd9\u4e9b\u9ad8\u8981\u6c42\u727a\u7272\u8fc7\u4e00\u4e9b\u7761\u7720\u65f6\u95f4\u3002\u4f46\u662f\uff0c\u8fd9\u662f\u4e3a\u4e86\u786e\u4fdd\u8bbe\u8ba1\u5728\u5ba2\u6237\u7b7e\u7f72\u786e\u8ba4\u4e4b\u524d\u8fbe\u5230\u6700\u9ad8\u8d28\u91cf\u3002 \u4e0d\u4ec5\u662f\u5e38\u89c4\u7684\u9879\u76ee\u7ecf\u7406 \u5f53\u4e9a\u592a\u56e2\u961f\u521a\u521a\u8d77\u6b65\u65f6\uff0c\u6211\u4eec [&hellip;]<\/p>\n","protected":false},"author":824,"featured_media":3568,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[321],"event_business_unit":[],"class_list":["post-4090","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-irt-clinical-trials"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.3.1 (Yoast SEO v26.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Innovative IRT Solutions: Almac\u2019s Commitment to Clinical Trial Quality and Innovation in APAC - Chinese - Clinical Technologies<\/title>\n<meta name=\"description\" content=\"Discover Almac&#039;s innovative IRT solutions and commitment to clinical trial quality and innovation in the APAC region.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innovative IRT Solutions: Almac\u2019s Commitment to Clinical Trial Quality and Innovation in APAC - Chinese\" \/>\n<meta property=\"og:description\" content=\"Discover Almac&#039;s innovative IRT solutions and commitment to clinical trial quality and innovation in the APAC region.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Technologies\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-07T13:05:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-04T11:13:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2024\/01\/MicrosoftTeams-image-73-e1739534917204.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"560\" \/>\n\t<meta property=\"og:image:height\" content=\"560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"brendanhagan\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@admin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"brendanhagan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/\"},\"author\":{\"name\":\"brendanhagan\",\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/#\/schema\/person\/1f1c1d742cb5a4f03636a1da933615d5\"},\"headline\":\"Innovative IRT Solutions: Almac\u2019s Commitment to Clinical Trial Quality and Innovation in APAC &#8211; Chinese\",\"datePublished\":\"2025-02-07T13:05:58+00:00\",\"dateModified\":\"2025-03-04T11:13:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/\"},\"wordCount\":83,\"publisher\":{\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2024\/01\/MicrosoftTeams-image-73-e1739534917204.jpg\",\"keywords\":[\"IRT Clinical Trials\"],\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/\",\"url\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/\",\"name\":\"Innovative IRT Solutions: Almac\u2019s Commitment to Clinical Trial Quality and Innovation in APAC - Chinese - Clinical Technologies\",\"isPartOf\":{\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2024\/01\/MicrosoftTeams-image-73-e1739534917204.jpg\",\"datePublished\":\"2025-02-07T13:05:58+00:00\",\"dateModified\":\"2025-03-04T11:13:44+00:00\",\"description\":\"Discover Almac's innovative IRT solutions and commitment to clinical trial quality and innovation in the APAC region.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#primaryimage\",\"url\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2024\/01\/MicrosoftTeams-image-73-e1739534917204.jpg\",\"contentUrl\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2024\/01\/MicrosoftTeams-image-73-e1739534917204.jpg\",\"width\":560,\"height\":560},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Clinical Technologies\",\"item\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Innovative IRT Solutions: Almac\u2019s Commitment to Clinical Trial Quality and Innovation in APAC &#8211; Chinese\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/#website\",\"url\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/\",\"name\":\"Clinical Technologies\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/#organization\",\"name\":\"Almac Group Ltd\",\"url\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2020\/04\/almac-logo-with-strapline.jpg\",\"contentUrl\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2020\/04\/almac-logo-with-strapline.jpg\",\"width\":643,\"height\":296,\"caption\":\"Almac Group Ltd\"},\"image\":{\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/#\/schema\/person\/1f1c1d742cb5a4f03636a1da933615d5\",\"name\":\"brendanhagan\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/97fe66cb6f22792c12b631a4de19c3a59fd276cfc0dc0c04b9652993785686df?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/97fe66cb6f22792c12b631a4de19c3a59fd276cfc0dc0c04b9652993785686df?s=96&d=mm&r=g\",\"caption\":\"brendanhagan\"},\"sameAs\":[\"https:\/\/x.com\/admin\"],\"url\":\"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/author\/brendanhagan\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Innovative IRT Solutions: Almac\u2019s Commitment to Clinical Trial Quality and Innovation in APAC - Chinese - Clinical Technologies","description":"Discover Almac's innovative IRT solutions and commitment to clinical trial quality and innovation in the APAC region.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/","og_locale":"en_GB","og_type":"article","og_title":"Innovative IRT Solutions: Almac\u2019s Commitment to Clinical Trial Quality and Innovation in APAC - Chinese","og_description":"Discover Almac's innovative IRT solutions and commitment to clinical trial quality and innovation in the APAC region.","og_url":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/","og_site_name":"Clinical Technologies","article_published_time":"2025-02-07T13:05:58+00:00","article_modified_time":"2025-03-04T11:13:44+00:00","og_image":[{"width":560,"height":560,"url":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2024\/01\/MicrosoftTeams-image-73-e1739534917204.jpg","type":"image\/jpeg"}],"author":"brendanhagan","twitter_card":"summary_large_image","twitter_creator":"@admin","twitter_misc":{"Written by":"brendanhagan","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#article","isPartOf":{"@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/"},"author":{"name":"brendanhagan","@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/#\/schema\/person\/1f1c1d742cb5a4f03636a1da933615d5"},"headline":"Innovative IRT Solutions: Almac\u2019s Commitment to Clinical Trial Quality and Innovation in APAC &#8211; Chinese","datePublished":"2025-02-07T13:05:58+00:00","dateModified":"2025-03-04T11:13:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/"},"wordCount":83,"publisher":{"@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/#organization"},"image":{"@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#primaryimage"},"thumbnailUrl":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2024\/01\/MicrosoftTeams-image-73-e1739534917204.jpg","keywords":["IRT Clinical Trials"],"articleSection":["Uncategorized"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/","url":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/","name":"Innovative IRT Solutions: Almac\u2019s Commitment to Clinical Trial Quality and Innovation in APAC - Chinese - Clinical Technologies","isPartOf":{"@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#primaryimage"},"image":{"@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#primaryimage"},"thumbnailUrl":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2024\/01\/MicrosoftTeams-image-73-e1739534917204.jpg","datePublished":"2025-02-07T13:05:58+00:00","dateModified":"2025-03-04T11:13:44+00:00","description":"Discover Almac's innovative IRT solutions and commitment to clinical trial quality and innovation in the APAC region.","breadcrumb":{"@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#primaryimage","url":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2024\/01\/MicrosoftTeams-image-73-e1739534917204.jpg","contentUrl":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2024\/01\/MicrosoftTeams-image-73-e1739534917204.jpg","width":560,"height":560},{"@type":"BreadcrumbList","@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/innovative-irt-solutions-almacs-commitment-to-clinical-trial-quality-and-innovation-in-apac-chinese\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Clinical Technologies","item":"https:\/\/www.almacgroup.com\/clinical-technologies\/"},{"@type":"ListItem","position":2,"name":"Innovative IRT Solutions: Almac\u2019s Commitment to Clinical Trial Quality and Innovation in APAC &#8211; Chinese"}]},{"@type":"WebSite","@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/#website","url":"https:\/\/www.almacgroup.com\/clinical-technologies\/","name":"Clinical Technologies","description":"","publisher":{"@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.almacgroup.com\/clinical-technologies\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/#organization","name":"Almac Group Ltd","url":"https:\/\/www.almacgroup.com\/clinical-technologies\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/#\/schema\/logo\/image\/","url":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2020\/04\/almac-logo-with-strapline.jpg","contentUrl":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-content\/uploads\/sites\/8\/2020\/04\/almac-logo-with-strapline.jpg","width":643,"height":296,"caption":"Almac Group Ltd"},"image":{"@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/#\/schema\/person\/1f1c1d742cb5a4f03636a1da933615d5","name":"brendanhagan","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.almacgroup.com\/clinical-technologies\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/97fe66cb6f22792c12b631a4de19c3a59fd276cfc0dc0c04b9652993785686df?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/97fe66cb6f22792c12b631a4de19c3a59fd276cfc0dc0c04b9652993785686df?s=96&d=mm&r=g","caption":"brendanhagan"},"sameAs":["https:\/\/x.com\/admin"],"url":"https:\/\/www.almacgroup.com\/clinical-technologies\/blogs\/author\/brendanhagan\/"}]}},"_links":{"self":[{"href":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-json\/wp\/v2\/posts\/4090","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-json\/wp\/v2\/users\/824"}],"replies":[{"embeddable":true,"href":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-json\/wp\/v2\/comments?post=4090"}],"version-history":[{"count":3,"href":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-json\/wp\/v2\/posts\/4090\/revisions"}],"predecessor-version":[{"id":4105,"href":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-json\/wp\/v2\/posts\/4090\/revisions\/4105"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-json\/wp\/v2\/media\/3568"}],"wp:attachment":[{"href":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-json\/wp\/v2\/media?parent=4090"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-json\/wp\/v2\/categories?post=4090"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-json\/wp\/v2\/tags?post=4090"},{"taxonomy":"event_business_unit","embeddable":true,"href":"https:\/\/www.almacgroup.com\/clinical-technologies\/wp-json\/wp\/v2\/event_business_unit?post=4090"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}